Skip to main content
Clinical Trials/ACTRN12605000114640
ACTRN12605000114640CompletedPhase 2

Assessment of quality of life of patients undergoing hypofractionated radiotherapy for the palliation of patients with advanced head and neck cancer who are unsuitable for an attempt at curative treatment

Dr Sandro Porceddu0 sites40 target enrollmentStarted: August 9, 2005Last updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
ot stated to o limit (—)
Sex
All

Inclusion Criteria

  • Biopsy proven squamus cell carcinoma (primary or regional nodal disease) of the head and neck, ineligible for curative treatment, performance status 0-2, life expectanccy of at least 4 months, written informed consent.

Exclusion Criteria

  • No exclusion criteria

Investigators

Sponsor
Dr Sandro Porceddu

Similar Trials